AML-392 Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm in Pediatric Patients With Tagraxofusp, a CD123-Targeted Therapy

  • Naveen Pemmaraju
  • , Branko Cuglievan
  • , Joseph Lasky
  • , Albert Kheradpour
  • , Nobuko Hijiya
  • , Anthony S. Stein
  • , Soheil Meshinchi
  • , Craig Mullen
  • , Emanuele Angelucci
  • , Luciana Vinti
  • , Tariq I. Mughal
  • , Anna Pawlowska

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)S244-S245
JournalClinical Lymphoma, Myeloma and Leukemia
Volume22
DOIs
StatePublished - Oct 2022

ASJC Scopus Subject Areas

  • Hematology
  • Oncology
  • Cancer Research

Keywords

  • AML
  • BPDCN
  • CD123
  • TAG
  • pediatric
  • plasmacytoid dendritic cell
  • tagraxofusp
  • targeted therapy

Cite this